Transfer of Treasury Shares

Venture Life Group PLC

13 July 2026

 

13 July 2026

VENTURE LIFE GROUP PLC

("Venture Life", "VLG" or the "Group")

Transfer of Treasury Shares

Venture Life Group PLC (AIM: VLG), a leader in product innovation, development and commercialisation within the global consumer healthcare sector, announces that on 10^th July 2026 the Company transferred 257,500 ordinary shares of 0.3p each in the Company ("Ordinary Shares") out of treasury to settle options exercised by a number of employees in accordance with the Company's employee share option scheme.

Following the transfer, the total number of Ordinary Shares in issue will be 128,860,145, with 7,535,904 Ordinary Shares held in treasury. Therefore, the total number of voting rights will be 121,324,241. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

For further information, please contact:

Venture Life Group PLC                                                                                         [phone]

Jerry Randall, Chief Executive Officer

Daniel Wells, Chief Financial Officer

Cavendish Capital Markets Limited (Nomad and Broker)                                [phone] 

Stephen Keys/George Lawson (Corporate Finance)

Michael Johnson (Sales) 

About Venture Life (www.venture-life.com)

Venture Life is an international consumer self-care company focused on commercialising products for the global self-care market. Headquartered in the UK, the Group's product portfolio includes Balance Activ in the area of women's intimate healthcare, Earol® supporting ENT care, Lift and Glucogel product ranges for energy and glucose management and hypoglycaemia, plus the Health & Her product range supporting the hormonal lifecycle.

The products, which are typically recommended by pharmacists or healthcare practitioners, are available primarily through health & beauty stores, pharmacies, grocery multiples and e-commerce channels and are sold globally. In the UK, Ireland and the USA these are supplied direct by the company to retailers, elsewhere they are supplied by the Group's international distribution partners. 

 

END